Medigene AG
MDGEF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -80.7% | 198.6% | 30.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 72.8% | 23.7% | 54.2% | 3% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -256% | 42% | -62.2% | -269.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -268.1% | -26.7% | -95.4% | -360.8% |
| EPS Diluted | -1.32 | -0.64 | -0.77 | -2.23 |
| % Growth | -106.3% | 16.9% | 65.5% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |